Calcium-entry blockers during porcine cardiopulmonary resuscitation.
1. Calcium-entry blockers increase the intramyocardial pH and decrease the intramyocardial Pco2 of ischaemic canine myocardium. However, the evidence documenting improvements in myocardial acidosis and in myocardial resuscitability after administration of calcium-entry blockers during cardiac arrest is incomplete. We therefore compared the effects of verapamil (0.05 mg/kg) and diltiazem (0.075 mg/kg) with those of saline placebo in an established porcine model of cardiac arrest and cardiopulmonary resuscitation. 2. After verapamil, six of 11 animals were successfully resuscitated; after diltiazem, five of 10; and after saline placebo, six of 10. Coronary perfusion and mean aortic pressures together with end-tidal CO2 concentration during precordial compression were predictive of resuscitation, independently of the drug or placebo. 3. Coronary vein pH decreased to 6.91 +/- 0.06 units (mean +/- SEM) with concurrent increases in PCO2 to levels exceeding 100 mmHg. Coronary vein lactate increased to a maximum of 7.5 +/- 0.6 mmol/l. Coronary vein acidaemia was accompanied by decreases in intramyocardial pH to 6.64 +/- 0.06 units. However, each of these differences between success and failure of resuscitation was unrelated to treatment with calcium-entry blockers. 4. Accordingly, neither verapamil nor diltiazem selectively altered coronary perfusion pressure, attenuated intramyocardial acidosis or improved resuscitability after porcine cardiac arrest and cardiopulmonary resuscitation.
von Planta
M
M
Department of Medicine, University of Health Sciences, Chicago Medical School, Illinois.
Weil
M H
MH
Gazmuri
R J
RJ
Ritz
M A
MA
Rackow
E C
EC
D000818:Animals; D001794:Blood Pressure; D004110:Diltiazem / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006323:Heart Arrest / Q000628:therapy*; D006863:Hydrogen-Ion Concentration; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D012151:Resuscitation / Q000379:methods*; D013552:Swine; D014700:Verapamil / Q000627:therapeutic use*
D014700:Verapamil; D004110:Diltiazem